Office of Professional Education

New this year, we are excited to announce several Product Theater opportunities. Product Theaters present new research findings on pharmaceutical products or disease states, provide product details, and highlight new drug and device approvals.


Please view the Product Theater schedule and additional information below. If you have any questions, please email

All Product Theaters will be held inside the Keystone Conference Center - Torreys Peak 1-2.

A Focus on Type 2 Inflammation in Disease

Sponsored by Sanofi Genzyme & Regeneron

Wednesday, February 2
7:15 - 8:15 pm

Dinner will be provided.
Coming Soon!

Position(s): Director

Affiliation(s): National Jewish Health Cohen Family Asthma Institute
Specialty: Pulmonology
Location: Denver, CO

Additional Positions
  • Professor, Pulmonary and Critical Care Medicine, University of Colorado School of Medicine, Aurora, CO; National Jewish Health, Denver, CO

Previous Positions
  • Assistant Professor, Medicine, Harvard Medical School, Boston, MA
  • Associate Director, Asthma Research Center, Brigham and Women’s Hospital, Boston, MA

  • MD, McGill University School of Medicine, Montreal, Quebec, Canada
  • Residency, Internal Medicine, Beth Israel Hospital, Boston, MA
  • Fellowship, Pulmonary and Critical Care Medicine, Beth Israel Medical Center; Brigham and Women’s Hospital; Massachusetts General Hospital, Boston, MA

Rethinking the Role of Nebulization in the Maintenance Treatment of COPD

Sponsored by VIATRIS

Thursday, February 3
10:15 - 11:15 am

Coming Soon!
Antonio Anzueto, MD is currently Professor of Medicine at the University of Texas Health Sciences Center at San Antonio, Texas and the Chief of the Pulmonary Disease Section at The South Texan Veterans Health Care System. He is a faculty at the Pulmonary Disease and Critical Care Medicine division. He earned his Doctor of Medicine degree at the Universidad de San Carlos de Guatemala and completed his training at both Hospital General San Juan de Dios, Guatemala City, Guatemala, and the University of Texas Health Science Center at San Antonio, Texas.
Dr. Anzueto is a reviewer for most prestigious scientific journals, including the New England Journal of Medicine, Journal of the American Medical Association (JAMA), European Respiratory Society Journal, American Journal of Respiratory Medicine and Critical Care. He is a member of the Scientific committee of the Global Initiative for Chronic Obstructive Lung Diseases (GOLD); Member of the 2011 ARDS consensus conference; Member of the ERS/ATS Acute Exacerbations Task force; Member of the 2005 and 2018 Community Acquired Pneumonia Guidelines Committee of the ATS/Infectious Diseases Society, and many other medical institutional and organizational committees.

Dr. Anzueto has published over 300 papers in peer-review journals, such as the New England Journal of Medicine, JAMA, European Respiratory Society Journal, American Journal of Respiratory Medicine and Critical Care, Intensive Care Medicine; Lancet, Archives of Internal Medicine; etc. and has a vast array of experiences as an invited speaker and moderator for many scientific meetings. His areas of interest include chronic obstructive pulmonary disease, pulmonary infections including chronic bronchitis, community acquired pneumonia, sepsis, and acute respiratory distress syndrome, n. Dr. Anzueto is the recipient of a number of awards ranging from the Du Pont/American College of Chest Physicians Young Investigator Award to Outstanding Teacher Award from the University of Texas Health Science Center, Best Pulmonary doctor in San Antonio Texas for several years since 2005; Fellow of the European Respiratory Society, and American Thoracic Society.

The First & Only Biologic Approved for the Treatment of Severe Asthma Without Phenotypic or Biomarker Limitations

Sponsored by Amgen AstraZeneca

Thursday, February 3
3:30 - 4:30 pm

To register for this Product Theater, please contact AJ DiPaulo via email at

Light refreshments will be provided.

  • Explore the role of TSLP in severe asthma and the MOA of TEZSPIRE
  • Review the efficacy and safety data of TEZSPIRE from key clinical trials
  • Understand the potential impact of TEZSPIRE in clinical practice

Partner, St. Paul Allergy & Asthma Clinic

Dr. Nicole Chase is an allergist with St. Paul Allergy & Asthma Clinic in St. Paul, Minnesota. She is a member of the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Clinical Immunology Society. She earned her medical degree in 2007 from the Medical College of Wisconsin. Following a residency in Pediatrics at Boston Children’s Hospital from 2007-2009, she pursued a fellowship in Allergy/Immunology at the Medical College of Wisconsin, graduating in 2012.

Severe Eosinophilic Asthma: A Targeted Treatment Approach

Sponsored by AstraZeneca

Friday, February 4
10:15 - 11:15 am

Light refreshments will be provided.

Airway eosinophils are considered to play an important role in the pathogenesis of asthma. Interleukin-5 is believed to be a key cytokine for the development, proliferation and activation of eosinophils. Benralizumab is an anti-interleukin-5 receptor α monoclonal antibody that depletes blood and airway eosinophils.

Director, UC Davis Asthma Network (UCAN) and the ROAD Center. ROAD (Reversible Obstructive Airway Diseases) includes COPD and the asthma-COPD overlap syndrome.

Philosophy of Care
Empathy is not an occupational hazard for me. The treatment of my patients' diseases may be impersonal, but the education and care of every patient I have is completely personal. Find the courage to change your health and lifestyle, and then find me to do a clinical trial of one. When you can't breathe, nothing else matters.
Clinical Interests
Dr. Louie is a pulmonologist and asthmatologist with special interests in severe asthma, the asthma-COPD overlap syndrome, and chronic obstructive pulmonary disease (COPD).
Research/Academic Interests
Dr. Louie's research interests include the immunology of asthma and chronic obstructive pulmonary disease, and chronic disease management of asthma and COPD to promote comprehensive and personalized care and patient safety.

Directorships at UC Davis Health:
1993-2006 - Director, Pulmonary Rehabilitation
1994-2014 - Director, Pulmonary Services Laboratory
1998 to present - Director, University of California Asthma Network (UCAN)
2001 to present - Director, Department of Respiratory Care
2006 to present - Medical Director, California Society for Respiratory Care (CSRC)

For hereditary angioedema (HAE), This Is Big: Learn About the First and Only Targeted Oral Prophylactic Therapy

Sponsored by BioCryst

Friday, February 4
3:30 - 4:30 pm

Learn about the first and only targeted oral prophylactic therapy for Hereditary Angioedema from BioCryst Pharmaceuticals.

Allergist/Immunologist at Rady Children's Hospital-San Diego and an Assistant Clinical Professor at UC San Diego School of Medicine.

Dr. Geng earned his bachelor's and master's degrees from Georgetown University. He then received his medical degree and residency training at Washington University School of Medicine in St. Louis before completing a fellowship in allergy and immunology at UC Los Angeles. He is board certified in internal medicine, allergy and immunology and clinical pharmacology.

Dr. Geng sees both pediatric and adult patients for allergic and immunologic conditions. He has a special interest in allergic conditions of the upper and lower airways as well as primary immunodeficiency disorders in both children and adults. In addition to general allergy clinics, he currently has a monthly immunology clinic focusing on primary immunodeficiency as well as a monthly Severe Asthma Clinic focusing on difficult-to-manage pediatric asthma patients.

Evidence for Use of a Biologic in the Management of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Sponsored by GSK

Friday, February 4
7:15 - 8:15 pm

This program will review the clinical evidence for the use of a biologic in adult patients with CRSwNP. The presentation will incorporate a patient case and discuss the role of eosinophilic inflammation in recurrent nasal polyps. This event will conclude with an optional Q&A.
Chief for the Division of Rhinology & Endoscopic Sinus and Skull Base Surgery and the Chief for the Division of Allergy, Eastern Virginia Medical School.

Not part of the official programming of the 44th Annual National Jewish Health Pulmonary and Allergy Update. 
The promotional activities are provided by the identified sponsor and are not certified for continuing education credit. The content of the Product Theaters and opinions expressed by presenters are those of the sponsor or presenters and not of National Jewish Health.